Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 14 Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Colorectal Neoplasms 9 Prostatic Neoplasms 8 Lung Neoplasms 7 Melanoma 6 Pancreatic Neoplasms 5 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplastic Cells, Circulating 4 Hematologic Neoplasms 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Glioblastoma 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Sarcoma 2 Recurrence 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Liver Diseases 2 Kidney Neoplasms 2 Glioma 2 Fibrosis 2

Interventions

olaparib 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hyperglycemia × Blood Specimen Collection × Clear all

NCT03978702 2022-01-06

IMMUNOPANC

Institut Paoli-Calmettes

Phase NA Unknown

Gastrointestinal

Hyperglycemia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡